239 related articles for article (PubMed ID: 11549685)
1. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency.
Gupta MK; Geller DH; Auchus RJ
J Clin Endocrinol Metab; 2001 Sep; 86(9):4416-23. PubMed ID: 11549685
[TBL] [Abstract][Full Text] [Related]
2. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5.
Geller DH; Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jan; 13(1):167-75. PubMed ID: 9892022
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.
Van Den Akker EL; Koper JW; Boehmer AL; Themmen AP; Verhoef-Post M; Timmerman MA; Otten BJ; Drop SL; De Jong FH
J Clin Endocrinol Metab; 2002 Dec; 87(12):5714-21. PubMed ID: 12466376
[TBL] [Abstract][Full Text] [Related]
4. The regulation of 17,20 lyase activity.
Miller WL; Auchus RJ; Geller DH
Steroids; 1997 Jan; 62(1):133-42. PubMed ID: 9029728
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of isolated 17,20 lyase deficiency.
Miller WL; Geller DH; Auchus RJ
Endocr Res; 1998; 24(3-4):817-25. PubMed ID: 9888582
[TBL] [Abstract][Full Text] [Related]
6. The genetic and functional basis of isolated 17,20-lyase deficiency.
Geller DH; Auchus RJ; Mendonça BB; Miller WL
Nat Genet; 1997 Oct; 17(2):201-5. PubMed ID: 9326943
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
[TBL] [Abstract][Full Text] [Related]
8. Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase/17,20-lyase deficiency: demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling.
Patocs A; Liko I; Varga I; Gergics P; Boros A; Futo L; Kun I; Bertalan R; Toth S; Pazmany T; Toth M; Szücs N; Horanyi J; Glaz E; Racz K
J Steroid Biochem Mol Biol; 2005 Nov; 97(3):257-65. PubMed ID: 16176874
[TBL] [Abstract][Full Text] [Related]
9. Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase.
Lin D; Black SM; Nagahama Y; Miller WL
Endocrinology; 1993 Jun; 132(6):2498-506. PubMed ID: 8504753
[TBL] [Abstract][Full Text] [Related]
10. Towards a unifying mechanism for CYP17 mutations that cause isolated 17,20-lyase deficiency.
Auchus RJ; Gupta MK
Endocr Res; 2002 Nov; 28(4):443-7. PubMed ID: 12530647
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of 17α-hydroxylase/17,20-lyase deficiency.
Yanase T; Imai T; Simpson ER; Waterman MR
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):973-9. PubMed ID: 22217842
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of putative serine-threonine phosphorylation sites proximal to Arg255 of human cytochrome P450c17 does not selectively promote its 17,20-lyase activity.
Souter I; Munir I; Mallick P; Weitsman SR; Geller DH; Magoffin DA
Fertil Steril; 2006 Apr; 85 Suppl 1():1290-9. PubMed ID: 16616104
[TBL] [Abstract][Full Text] [Related]
13. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding.
Sherbet DP; Tiosano D; Kwist KM; Hochberg Z; Auchus RJ
J Biol Chem; 2003 Dec; 278(49):48563-9. PubMed ID: 14504283
[TBL] [Abstract][Full Text] [Related]
14. A Homodimer Model Can Resolve the Conundrum as to How Cytochrome P450 Oxidoreductase and Cytochrome b5 Compete for the Same Binding Site on Cytochrome P450c17.
Holien JK; Parker MW; Conley AJ; Corbin CJ; Rodgers RJ; Martin LL
Curr Protein Pept Sci; 2017; 18(5):515-521. PubMed ID: 28000554
[TBL] [Abstract][Full Text] [Related]
15. Molecular evolution of adrenarche: structural and functional analysis of p450c17 from four primate species.
Arlt W; Martens JW; Song M; Wang JT; Auchus RJ; Miller WL
Endocrinology; 2002 Dec; 143(12):4665-72. PubMed ID: 12446594
[TBL] [Abstract][Full Text] [Related]
16. Modeling and mutagenesis of the active site of human P450c17.
Lin D; Zhang LH; Chiao E; Miller WL
Mol Endocrinol; 1994 Mar; 8(3):392-402. PubMed ID: 8015556
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer.
Auchus RJ; Lee TC; Miller WL
J Biol Chem; 1998 Feb; 273(6):3158-65. PubMed ID: 9452426
[TBL] [Abstract][Full Text] [Related]
18. Novel P450c17 mutation H373D causing combined 17alpha-hydroxylase/17,20-lyase deficiency.
Sahakitrungruang T; Tee MK; Speiser PW; Miller WL
J Clin Endocrinol Metab; 2009 Aug; 94(8):3089-92. PubMed ID: 19470621
[TBL] [Abstract][Full Text] [Related]
19. Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species.
Brock BJ; Waterman MR
Biochemistry; 1999 Feb; 38(5):1598-606. PubMed ID: 9931027
[TBL] [Abstract][Full Text] [Related]
20. The post-translational regulation of 17,20 lyase activity.
Miller WL; Tee MK
Mol Cell Endocrinol; 2015 Jun; 408():99-106. PubMed ID: 25224484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
